Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ARQ · Nasdaq · United States · Miscellaneous Chemical Products
In shortArq, Inc. is loss-making, burns cash and carries moderate debt, with revenue growing (+10.4% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -44.0% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -43.7% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -27.2% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -21.3% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.04× | 20/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.17× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -21.62× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 1.53 | 11/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -9.4% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 1 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 5 | 20/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 20.5% | 35/100 |
| Operating margin volatility | 18.8% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 5.3% | 46/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 100 | 103 | 99 | 109 | 120 |
| Cost of revenue | – | – | 67 | 70 | 87 |
| Gross profit | – | – | 32 | 39 | 34 |
| Research & development | 0.4 | 2.1 | 3.3 | 4.1 | 7.3 |
| Selling, general & admin | – | – | 34 | 29 | 23 |
| Operating income | 4.9 | (12) | (13) | (2) | (53) |
| Interest expense | 1.5 | 0.3 | 3 | 3.3 | 2.4 |
| Pre-tax income | 76 | (8.7) | (12) | (5.3) | (53) |
| Income tax | 16 | 0.2 | 0.2 | (0.2) | 0 |
| Net income | 60 | (8.9) | (12) | (5.1) | (53) |
| Diluted EPS | $3.27 | −$0.48 | −$0.42 | −$0.14 | −$1.27 |
| Diluted shares (millions) | 18 | 18 | 29 | 36 | 42 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
1.53 Grey zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
2/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 10, 2026